Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals

Routes of drug administration and the corresponding physicochemical characteristics of a given route play significant roles in therapeutic efficacy and short term/long term biological effects. Each delivery method has favorable aspects and limitations, each requiring a specific delivery vehicles design. Among various routes, oral delivery has been recognized as the most attractive method, mainly due to its potential for solid formulations with long shelf life, sustained delivery, ease of administration and intensified immune response. At the same time, a few challenges exist in oral delivery, which have been the main research focus in the field in the past few years. The present work concisely reviews different administration routes as well as the advantages and disadvantages of each method, highlighting why oral delivery is currently the most promising approach. Subsequently, the present work discusses the main obstacles for oral systems and explains the most recent solutions proposed to deal with each issue.

[1]  D. Kufe,et al.  Mucins in cancer: function, prognosis and therapy , 2009, Nature Reviews Cancer.

[2]  P. Artursson,et al.  Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models. , 2010, Journal of pharmaceutical sciences.

[3]  T. Anirudhan,et al.  Novel Thiolated Chitosan-Polyethyleneglycol blend/Montmorillonite composite formulations for the oral delivery of insulin , 2018, Bioactive Carbohydrates and Dietary Fibre.

[4]  L. Valon,et al.  Dying under pressure: cellular characterisation and in vivo functions of cell death induced by compaction , 2019, Biology of the cell.

[5]  A. Pannier,et al.  Oral Non-Viral Gene Delivery for Applications in DNA Vaccination and Gene Therapy. , 2018, Current opinion in biomedical engineering.

[6]  J. Rosenstock,et al.  Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial , 2017, JAMA.

[7]  Limin Guo,et al.  Double mesoporous silica shelled spherical/ellipsoidal nanostructures: Synthesis and hydrophilic/hydrophobic anticancer drug delivery , 2011 .

[8]  James M. Wilson,et al.  Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Frank Caruso,et al.  Nanoengineering of particle surfaces. , 2001 .

[10]  V. Torchilin Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. , 2005, Advanced drug delivery reviews.

[11]  V. Ranade Drug Delivery Systems. 6. Transdermal Drug Delivery , 1991, Journal of clinical pharmacology.

[12]  V. Khutoryanskiy,et al.  Biomedical applications of hydrogels: A review of patents and commercial products , 2015 .

[13]  Shan Ding,et al.  Liposomes coated with thiolated chitosan as drug carriers of curcumin. , 2017, Materials science & engineering. C, Materials for biological applications.

[14]  Anja Boisen,et al.  Development of electrosprayed mucoadhesive chitosan microparticles. , 2018, Carbohydrate polymers.

[15]  D. Roberts,et al.  gastrointestinal tract development , 2008 .

[16]  Samir Mitragotri,et al.  Intestinal mucoadhesive devices for oral delivery of insulin , 2016, Bioengineering & translational medicine.

[17]  P. H. Nascimento,et al.  Macropored microparticles with a core–shell architecture for oral delivery of biopharmaceuticals , 2018, Archives of pharmacal research.

[18]  C. Destrieux,et al.  Anatomical study of the length of the human intestine , 2002, Surgical and Radiologic Anatomy.

[19]  Tejal A Desai,et al.  Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Xing Tang,et al.  Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. , 2012, International journal of pharmaceutics.

[21]  T. Kissel,et al.  Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  M. Weindling Avery's Diseases of the Newborn , 2013 .

[23]  M. Goto,et al.  Intestinal patches with an immobilized solid-in-oil formulation for oral protein delivery. , 2012, Acta biomaterialia.

[24]  F. Quan,et al.  Microfabrication for Drug Delivery , 2016, Materials.

[25]  H. M. Nielsen,et al.  Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  H Cheng,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. IV. Paneth cells. , 1974, The American journal of anatomy.

[27]  Yang Chen,et al.  Novel chemical permeation enhancers for transdermal drug delivery , 2014 .

[28]  Gunnar C. Hansson,et al.  The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions , 2010, Proceedings of the National Academy of Sciences.

[29]  Stefan Zauscher,et al.  Advances in mucin mimic synthesis and applications in surface science , 2018, Current Opinion in Colloid & Interface Science.

[30]  C. Montemagno,et al.  Facile fabrication of microparticles with pH-responsive macropores for small intestine targeted drug formulation , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  M. Schenk,et al.  The mucosal immune system at the gastrointestinal barrier. , 2008, Best practice & research. Clinical gastroenterology.

[32]  J. B. Vicente,et al.  Scale-up methodology for pharmaceutical spray drying , 2010 .

[33]  H. Möhwald,et al.  Halloysite clay nanotubes for controlled release of protective agents. , 2008, ACS nano.

[34]  T. Nisisako,et al.  High-volume production of single and compound emulsions in a microfluidic parallelization arrangement coupled with coaxial annular world-to-chip interfaces. , 2012, Lab on a chip.

[35]  R. Sun,et al.  Revealing strong nanocomposite hydrogels reinforced by cellulose nanocrystals: insight into morphologies and interactions. , 2013, ACS applied materials & interfaces.

[36]  Yufang Zhu,et al.  Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy. , 2017, Small.

[37]  H Lennernäs,et al.  Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.

[38]  Alan Riboldi-Tunnicliffe,et al.  Tropoelastin Implants That Accelerate Wound Repair , 2018, Advanced healthcare materials.

[39]  Bijay Singh,et al.  Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum. , 2016, Biomaterials.

[40]  A. Bernkop‐Schnürch,et al.  Thiolated chitosans. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  Yi Yan Yang,et al.  Co-delivery of drugs and plasmid DNA for cancer therapy. , 2016, Advanced drug delivery reviews.

[42]  David A Weitz,et al.  Polymer microcapsules with programmable active release. , 2013, Journal of the American Chemical Society.

[43]  Liqun Zhang,et al.  Halloysite Clay Nanotubes for Loading and Sustained Release of Functional Compounds , 2016, Advanced materials.

[44]  Yangchao Luo,et al.  Recent advances of polysaccharide-based nanoparticles for oral insulin delivery. , 2018, International journal of biological macromolecules.

[45]  R. Langer,et al.  pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices , 2015, Nature materials.

[46]  S. Melgar,et al.  Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models. , 2011, Drug discovery today.

[47]  L. Klouda Thermoresponsive hydrogels in biomedical applications: A seven-year update. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[48]  C. P. Leblond,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. , 1974, The American journal of anatomy.

[49]  Radivoje Prodanovic,et al.  A high-throughput cellulase screening system based on droplet microfluidics. , 2014, Biomicrofluidics.

[50]  T J Flotte,et al.  Photomechanical transcutaneous delivery of macromolecules. , 1998, The Journal of investigative dermatology.

[51]  Lorne A. Babiuk,et al.  Mechanisms of Action of Adjuvants , 2013, Front. Immunol..

[52]  Kevin J. De France,et al.  Enhanced Mechanical Properties in Cellulose Nanocrystal-Poly(oligoethylene glycol methacrylate) Injectable Nanocomposite Hydrogels through Control of Physical and Chemical Cross-Linking. , 2016, Biomacromolecules.

[53]  Cees W J Oomens,et al.  Penetration and delivery characteristics of repetitive microjet injection into the skin. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Y. Chen,et al.  Multifunctional magnetically removable nanogated lids of Fe3O4–capped mesoporous silica nanoparticles for intracellular controlled release and MR imaging , 2011 .

[55]  J. Zink,et al.  Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Cheng Sun,et al.  Polymer grafted-magnetic halloysite nanotube for controlled and sustained release of cationic drug. , 2017, Journal of colloid and interface science.

[57]  Cleo Choong,et al.  Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. , 2013, Tissue engineering. Part B, Reviews.

[58]  C. Mou,et al.  Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. , 2010, Angewandte Chemie.

[59]  Y. Lvov,et al.  Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold. , 2018, Advances in colloid and interface science.

[60]  J. S. Beck,et al.  Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism , 1992, Nature.

[61]  B. Ferraiolo,et al.  Protein Pharmacokinetics and Metabolism , 1992, Pharmaceutical Biotechnology.

[62]  L. A. Christensen,et al.  pH‐Profile and regional transit times of the normal gut measured by a radiotelemetry device , 1989, Alimentary pharmacology & therapeutics.

[63]  I. Foulds,et al.  Three-dimensional parallelization of microfluidic droplet generators for a litre per hour volume production of single emulsions. , 2014, Lab on a chip.

[64]  Lena Holm,et al.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria , 2010, Gut microbes.

[65]  Laura M Ensign,et al.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.

[66]  Justin Hanes,et al.  A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[67]  Yuejun Kang,et al.  Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue. , 2018, Colloids and surfaces. B, Biointerfaces.

[68]  R. Mrsny,et al.  Mechanistic studies of a cell‐permeant peptide designed to enhance myosin light chain phosphorylation in polarized intestinal epithelia , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[69]  D. Issadore,et al.  Recent developments in scale-up of microfluidic emulsion generation via parallelization , 2016, Korean Journal of Chemical Engineering.

[70]  Kaoru Shimamura,et al.  Morphology and structure of highly elastic poly(vinyl alcohol) hydrogel prepared by repeated freezing-and-melting , 1986 .

[71]  E. Dimagno,et al.  Fate of pancreatic enzymes during small intestinal aboral transit in humans. , 1986, The American journal of physiology.

[72]  H. Santos,et al.  Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals , 2017 .

[73]  Yen Cu,et al.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. , 2009, Molecular pharmaceutics.

[74]  Hiroshi Noguchi,et al.  Fusion pathways of vesicles: A Brownian dynamics simulation , 2001 .

[75]  Mingshi Yang,et al.  Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake , 2011, International journal of nanomedicine.

[76]  A. Bernkop‐Schnürch,et al.  Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. , 2006, International journal of pharmaceutics.

[77]  A. V. Yadav,et al.  Bioavailability of intranasal drug delivery system , 2008 .

[78]  M. Dias,et al.  Alginate microparticles as oral colon drug delivery device: A review. , 2017, Carbohydrate polymers.

[79]  E. Doelker,et al.  Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery , 1996 .

[80]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[81]  G. Carta,et al.  Protein Transport in Constrained Anionic Hydrogels: Diffusion and Boundary-Layer Mass Transfer , 2001 .

[82]  G. Stucky,et al.  Assembly of Nanoparticles into Hollow Spheres Using Block Copolypeptides , 2002 .

[83]  B. Sarmento,et al.  Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides , 2018, Peptides.

[84]  N Salessiotis,et al.  Measurement of the diameter of the pylorus in man. I. Experimental project for clinical application. , 1972, American journal of surgery.

[85]  T. Okano,et al.  Molecular design for missile drug: Synthesis of adriamycin conjugated with immunoglobulin G using poly(ethylene glycol)-block-poly(aspartic acid) as intermediate carrier , 1989 .

[86]  W. B. Weber,et al.  Novel Pemulen/Pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules: Evaluation of mucoadhesion and vaginal permeation. , 2017, Materials science & engineering. C, Materials for biological applications.

[87]  Fei Xu,et al.  Structured Macroporous Hydrogels: Progress, Challenges, and Opportunities , 2018, Advanced healthcare materials.

[88]  J. Langer,et al.  Small Intestine: Anatomy and Structural Anomalies , 2009 .

[89]  R. Müller,et al.  Development of cationic nanocrystals for ocular delivery. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[90]  N. Nasongkla,et al.  Controlling the burst release of doxorubicin from polymeric depots via adjusting hydrophobic/hydrophilic properties , 2018, Journal of Drug Delivery Science and Technology.

[91]  Smart Microparticles with a pH-responsive Macropore for Targeted Oral Drug Delivery , 2017, Scientific Reports.

[92]  K. Leong,et al.  In vitro and in vivo models for the study of oral delivery of nanoparticles. , 2013, Advanced drug delivery reviews.

[93]  Dimitrios J. Giliopoulos,et al.  PLGA/SBA‐15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[94]  M. Torres-Lugo,et al.  Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin , 1999 .

[95]  B. Chassaing,et al.  Identification of Inner Mucus-Associated Bacteria by Laser Capture Microdissection , 2018, Cellular and molecular gastroenterology and hepatology.

[96]  Y. Jiao,et al.  Hydrogels for Biomedical Applications: Their Characteristics and the Mechanisms behind Them , 2017, Gels.

[97]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[98]  H Cheng,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. II. Mucous cells. , 1974, The American journal of anatomy.

[99]  Yehuda G. Assaraf,et al.  β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells , 2016, Oncotarget.

[100]  V. S. Lin,et al.  Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. , 2009, Journal of the American Chemical Society.

[101]  M. Ramasubramanian,et al.  A three-dimensional microfluidic approach to scaling up microencapsulation of cells , 2012, Biomedical Microdevices.

[102]  Alejandro Sosnik,et al.  Polymeric micelles in mucosal drug delivery: Challenges towards clinical translation. , 2015, Biotechnology advances.

[103]  A. Hermansson,et al.  Characterization of protein gels by scanning and transmission electron microscopy A methodology study of soy protein gels , 1981 .

[104]  Mark R Prausnitz,et al.  Drug delivery using microneedle patches: not just for skin , 2018, Expert opinion on drug delivery.

[105]  C. Montemagno,et al.  A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment , 2013, PloS one.

[106]  Samuel K Lai,et al.  PEGylation for enhancing nanoparticle diffusion in mucus☆ , 2017, Advanced drug delivery reviews.

[107]  Melissa D. Krebs,et al.  Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis in vitro , 2018, RSC advances.

[108]  Christian Holtze,et al.  Large-scale droplet production in microfluidic devices—an industrial perspective , 2013 .

[109]  R. Smallwood,et al.  Upper gastrointestinal tract , 1995, The Medical journal of Australia.

[110]  Amir Bein,et al.  Intestinal tight junctions are severely altered in NEC preterm neonates. , 2017, Pediatrics and neonatology.

[111]  Y. Anissimov,et al.  Microneedles as the technique of drug delivery enhancement in diverse organs and tissues. , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[112]  Melanie Maxwell,et al.  Complications of blood transfusion , 2006 .

[113]  Liang-Yin Chu,et al.  Reply to the 'Comment on "Wetting-induced formation of controllable monodisperse multiple emulsions in microfluidics"' by J. Guzowski and P. Garstecki, Lab Chip, 2014, 14, DOI: 10.1039/C3LC51229K. , 2014, Lab on a chip.

[114]  Jasmim Leal,et al.  Physicochemical properties of mucus and their impact on transmucosal drug delivery. , 2017, International journal of pharmaceutics.

[115]  Y. Bae,et al.  Evaluation of drug penetration with cationic micelles and their penetration mechanism using an in vitro tumor model. , 2016, Biomaterials.

[116]  Sanjun Shi,et al.  Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12. , 2013, Molecular pharmaceutics.

[117]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[118]  Robert Langer,et al.  Perspective: Special delivery for the gut , 2015, Nature.

[119]  P. Butler,et al.  Injectable Pore-Forming Hydrogel Scaffolds for Complex Wound Tissue Engineering: Designing and Controlling Their Porosity and Mechanical Properties. , 2016, Tissue engineering. Part B, Reviews.

[120]  C. Montemagno,et al.  The osmotic stress response of split influenza vaccine particles in an acidic environment , 2014, Archives of pharmacal research.

[121]  Rama Bansil,et al.  The biology of mucus: Composition, synthesis and organization☆ , 2017, Advanced drug delivery reviews.

[122]  A. Mohamad,et al.  Properties and Applications of Polyvinyl Alcohol, Halloysite Nanotubes and Their Nanocomposites , 2015, Molecules.

[123]  Lijie Tang,et al.  Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus , 2018, Microbial Cell Factories.

[124]  R. Gambari,et al.  Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[125]  David J. Mooney,et al.  Designing hydrogels for controlled drug delivery. , 2016, Nature reviews. Materials.

[126]  B. Luppi,et al.  Microparticles based on chitosan/carboxymethylcellulose polyelectrolyte complexes for colon delivery of vancomycin. , 2016, Carbohydrate polymers.

[127]  J. Mestecky,et al.  Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells , 2010, PLoS pathogens.

[128]  Y. Lvov,et al.  The application of halloysite tubule nanoclay in drug delivery , 2016, Expert opinion on drug delivery.

[129]  L. Holm,et al.  The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[130]  M. Bermejo,et al.  PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[131]  Min Zhang,et al.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. , 2009, Small.

[132]  A. Bernkop‐Schnürch,et al.  Preparation and characterization of mucus-penetrating papain/poly(acrylic acid) nanoparticles for oral drug delivery applications , 2012, Journal of Nanoparticle Research.

[133]  F. Tamanoi,et al.  Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. , 2015, Advanced drug delivery reviews.

[134]  Hyun-Jong Cho,et al.  Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity. , 2014, International journal of pharmaceutics.

[135]  L. Jorgensen,et al.  Alternative routes of administration for systemic delivery of protein pharmaceuticals. , 2008, Drug discovery today. Technologies.

[136]  Michael Sultan,et al.  Esophageal diameter and the treatment of achalasia , 1969, The American Journal of Digestive Diseases.

[137]  M. Kostoglou,et al.  Thiolated Chitosan Masked Polymeric Microspheres with Incorporated Mesocellular Silica Foam (MCF) for Intranasal Delivery of Paliperidone , 2017, Polymers.

[138]  J. Dressman,et al.  Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women , 1990, Pharmaceutical Research.

[139]  Sorell Massenburg,et al.  Clogging in parallelized tapered microfluidic channels , 2016 .

[140]  Rachel K. O'Reilly,et al.  Advances and challenges in smart and functional polymer vesicles , 2009 .

[141]  Flavia Laffleur,et al.  In vitro characterization of insulin containing thiomeric microparticles as nasal drug delivery system. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[142]  S. Mitragotri,et al.  Role of nanoparticle size, shape and surface chemistry in oral drug delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[143]  Feng Xu,et al.  Engineering cell alignment in vitro. , 2014, Biotechnology advances.

[144]  Alessio Fasano,et al.  Tight junction modulation and its relationship to drug delivery. , 2006, Advanced drug delivery reviews.

[145]  Siling Wang,et al.  pH‐ and NIR Light‐Responsive Micelles with Hyperthermia‐Triggered Tumor Penetration and Cytoplasm Drug Release to Reverse Doxorubicin Resistance in Breast Cancer , 2015 .

[146]  Bh,et al.  RECENT TECHNIQUES IN NASAL DRUG DELIVERY: A REVIEW , 2010 .

[147]  Zhenguo Liu,et al.  Porous microsphere and its applications , 2013, International journal of nanomedicine.

[148]  Diane J Burgess,et al.  Effect of acidic pH on PLGA microsphere degradation and release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[149]  M. Brenner,et al.  Robust scalable high throughput production of monodisperse drops. , 2016, Lab on a chip.

[150]  Cecilia Sahlgren,et al.  Mesoporous silica nanoparticles in medicine--recent advances. , 2013, Advanced drug delivery reviews.

[151]  M. Wilcox,et al.  Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[152]  C. Liao,et al.  Hydrogels for biomedical applications. , 2013 .

[153]  S. Cuzzocrea,et al.  Pharmacodynamical effects of orally administered exenatide nanoparticles embedded in gastro‐resistant microparticles , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[154]  A. Abate,et al.  Block-and-break generation of microdroplets with fixed volume. , 2013, Biomicrofluidics.

[155]  Mariusz Skwarczynski,et al.  Micro- and nanotechnology in vaccine development , 2016 .

[156]  G. Amidon,et al.  Physiological parameters for oral delivery and in vitro testing. , 2010, Molecular pharmaceutics.

[157]  J. Zink,et al.  Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core-shell mesoporous silica nanoparticles. , 2015, Nanoscale.

[158]  Samir Mitragotri,et al.  Intestinal patch systems for oral drug delivery , 2017, Current opinion in pharmacology.

[159]  André R. Studart,et al.  High-Throughput Step Emulsification for the Production of Functional Materials Using a Glass Microfluidic Device , 2017 .

[160]  Morgan Le Guen,et al.  Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. , 2012, Pharmacology & therapeutics.

[161]  J. Lai,et al.  Functional assessment of cross-linked porous gelatin hydrogels for bioengineered cell sheet carriers. , 2010, Biomacromolecules.

[162]  D. Maysinger,et al.  Telodendrimers for Physical Encapsulation and Covalent Linking of Individual or Combined Therapeutics. , 2017, Molecular pharmaceutics.

[163]  Young Bin Choy,et al.  Nanostructured mucoadhesive microparticles to enhance oral drug bioavailability , 2017 .

[164]  Dimitrios J. Giliopoulos,et al.  Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[165]  Samir Mitragotri,et al.  Intestinal Patches for Oral Drug Delivery , 2002, Pharmaceutical Research.

[166]  Hee-Jeong Cho,et al.  Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy , 2011, Pharmaceutical Research.

[167]  Chandra P Sharma,et al.  Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. , 2010, Acta biomaterialia.

[168]  Ying Wang,et al.  Mesoporous silica nanoparticles in drug delivery and biomedical applications. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[169]  M. Kostoglou,et al.  Chitosan derivatives as effective nanocarriers for ocular release of timolol drug. , 2015, International journal of pharmaceutics.

[170]  Zhirong Zhang,et al.  Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[171]  Ali Khademhosseini,et al.  Controlling the porosity and microarchitecture of hydrogels for tissue engineering. , 2010, Tissue engineering. Part B, Reviews.

[172]  Hui-Fen Wu,et al.  Layer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine. , 2015, Biomaterials.

[173]  Yoshiaki Fukushima,et al.  Synthesis of highly ordered mesoporous materials from a layered polysilicate , 1993 .

[174]  Yves-Jacques Schneider,et al.  Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[175]  H. Daniell,et al.  Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[176]  F. Gao,et al.  Mucus‐penetrating phage‐displayed peptides for improved transport across a mucus‐like model , 2018, International journal of pharmaceutics.

[177]  M. Rodger,et al.  Drawing up and administering intramuscular injections: a review of the literature. , 2000, Journal of advanced nursing.

[178]  R. Langer,et al.  A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. , 1997, Journal of pharmaceutical sciences.

[179]  M. Gaeti,et al.  Mucoadhesive Properties of Thiolated Pectin-Based Pellets Prepared by Extrusion-Spheronization Technique. , 2017, Journal of pharmaceutical sciences.

[180]  Zhirong Zhang,et al.  Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. , 2015, ACS nano.

[181]  Lehui Lu,et al.  Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. , 2015, Biomaterials.

[182]  M. Vallet‐Regí,et al.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery , 2015, Expert opinion on drug delivery.

[183]  N. Rigby,et al.  The influence of small intestinal mucus structure on particle transport ex vivo. , 2015, Colloids and surfaces. B, Biointerfaces.

[184]  H. Noteborn,et al.  Drug delivery systems. , 1989, Current opinion in oncology.

[185]  Gary P. Martin,et al.  Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects , 2006, Drug delivery.

[186]  V. Torchilin,et al.  Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. , 2006, International journal of pharmaceutics.

[187]  Ashutosh Badola,et al.  SUSTAINED RELEASE MATRIX TECHNOLOGY AND RECENT ADVANCE IN MATRIX DRUG DELIVERY SYSTEM: A REVIEW , 2017 .

[188]  Younan Xia,et al.  Polymer hollow particles with controllable holes in their surfaces , 2005, Nature materials.

[189]  M. Donovan,et al.  Overview of intranasally delivered peptides: key considerations for pharmaceutical development , 2018, Expert opinion on drug delivery.

[190]  R. S. Byrne,et al.  Use of commercial porous ceramic particles for sustained drug delivery. , 2002, International journal of pharmaceutics.

[191]  N. Peppas,et al.  Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[192]  T. Bein,et al.  Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery. , 2015, Nanoscale.

[193]  A. Bernkop‐Schnürch,et al.  Thiolated chitosans. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[194]  Robert Langer,et al.  Microneedles for drug delivery via the gastrointestinal tract. , 2015, Journal of pharmaceutical sciences.

[195]  M. Stieger,et al.  Denaturation and in Vitro Gastric Digestion of Heat-Treated Quinoa Protein Isolates Obtained at Various Extraction pH , 2016, Food Biophysics.

[196]  Jean-Christophe Leroux,et al.  Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts. , 2016, Advanced drug delivery reviews.

[197]  L. Fändriks,et al.  Surface area of the digestive tract – revisited , 2014, Scandinavian journal of gastroenterology.

[198]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[199]  E. Mathiowitz,et al.  Double-walled polymer microspheres for controlled drug release , 1994, Nature.

[200]  D. Weitz,et al.  Throughput enhancement of parallel step emulsifier devices by shear-free and efficient nozzle clearance. , 2019, Lab on a chip.

[201]  R. Cone,et al.  Barrier properties of mucus. , 2009, Advanced drug delivery reviews.

[202]  Enzo Terreno,et al.  Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. , 2010, Biomaterials.

[203]  L. Lichtenberger The hydrophobic barrier properties of gastrointestinal mucus. , 1995, Annual review of physiology.

[204]  T. Choli-Papadopoulou,et al.  Design of a Multifunctional Nanoengineered PLLA Surface by Maximizing the Synergies between Biochemical and Surface Design Bactericidal Effects , 2018, ACS omega.

[205]  A. Basit,et al.  Mucoadhesion and the gastrointestinal tract. , 2008, Critical reviews in therapeutic drug carrier systems.

[206]  Haeshin Lee,et al.  Chitosan-catechol: a polymer with long-lasting mucoadhesive properties. , 2015, Biomaterials.

[207]  D. Wirtz,et al.  Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus , 2004, Biotechnology progress.

[208]  S. Stolnik,et al.  Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery , 2018, Expert opinion on drug delivery.

[209]  Howard A Stone,et al.  Mechanism for clogging of microchannels. , 2006, Physical review. E, Statistical, nonlinear, and soft matter physics.

[210]  David J Brayden,et al.  Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. , 2005, Drug discovery today.

[211]  Veerle Cnudde,et al.  Porous gelatin hydrogels: 1. Cryogenic formation and structure analysis. , 2007, Biomacromolecules.

[212]  Ung-Jin Kim,et al.  Structure and properties of silk hydrogels. , 2004, Biomacromolecules.

[213]  K. Korttila,et al.  Venous Complications After Intravenous Injection of Diazepam, Flunitrazepam, Thiopentone and Etomidate , 1980 .

[214]  Jianhong Yang,et al.  Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery. , 2018, International journal of pharmaceutics.

[215]  M. Wirth,et al.  Lectin-Mediated Bioadhesion: Preparation, Stability and Caco-2 Binding of Wheat Germ Agglutinin-Functionalized Poly(D,L-lactic-co-glycolic acid)-Microspheres , 2000, Journal of drug targeting.

[216]  M. Stringer,et al.  Sciatic nerve injury from intramuscular injection: a persistent and global problem , 2010, International journal of clinical practice.

[217]  Yunzhe Ma,et al.  Vaccine Delivery to the Oral Cavity Using Coated Microneedles Induces Systemic and Mucosal Immunity , 2014, Pharmaceutical Research.

[218]  K. Loré,et al.  Local innate immune responses in the vaccine adjuvant-injected muscle , 2016, Clinical & translational immunology.

[219]  S. Mitragotri,et al.  Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[220]  R. Mrsny,et al.  Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[221]  S. F. Zawadzki,et al.  Spray-dried Eudragit® L100 microparticles containing ferulic acid: Formulation, in vitro cytoprotection and in vivo anti-platelet effect. , 2016, Materials science & engineering. C, Materials for biological applications.

[222]  L. Nicoll,et al.  Intramuscular injection: an integrative research review and guideline for evidence-based practice. , 2002, Applied nursing research : ANR.

[223]  M. Bakhtiyari,et al.  The effects of hydrocortisone on tight junction genes in an in vitro model of the human fallopian epithelial cells. , 2018, European journal of obstetrics, gynecology, and reproductive biology.

[224]  Xiuhua Wang,et al.  Design and intestinal mucus penetration mechanism of core‐shell nanocomplex , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[225]  Neil D. Rawlings,et al.  [2] Families of serine peptidases , 1994, Methods in Enzymology.

[226]  M. Goto,et al.  An enteric-coated dry emulsion formulation for oral insulin delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.